3821 - 3830 of 8818 Results
Title
Year
- The IgLON Family Member Negr1 Promotes Neuronal Arborization Acting as Soluble Factor via FGFR22016OPENTitle: The IgLON Family Member Negr1 Promotes Neuronal Arborization Acting as Soluble Factor via FGFR2Journal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2015.00089Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2015.00089/pdfCitation Count: 59
-
RESTRICTEDTitle: Design, synthesis, and evaluation of a selective chemosensor for leucine-rich repeat kinase 2Journal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 24Issue #: 24Start Page: 5648End Page: 5651Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2014.10.079Citation Count: 8
-
OPENTitle: Ubiquitin specific protease-13 independently regulates parkin ubiquitination and alpha-synuclein clearance in alpha-synucleinopathiesJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 28Issue #: 4Start Page: 548End Page: 560Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddy365Best OA location URL: https://academic.oup.com/hmg/article-pdf/28/4/548/27636558/ddy365.pdfCitation Count: 65
-
RESTRICTEDTitle: The Role of Stable α-Synuclein Oligomers in the Molecular Events Underlying Amyloid FormationJournal Name: Journal of the American Chemical SocietyPublisher: American Chemical Society (ACS)Vol: 136Issue #: 10Start Page: 3859End Page: 3868Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/ja411577tCitation Count: 238
-
OPENTitle: Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesisJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.31012Best OA location URL: https://doi.org/10.7554/elife.31012Citation Count: 461
-
OPENTitle: Comparison of voluntary and reflex cough effectiveness in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 11Start Page: 1226End Page: 1230Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.09.010Best OA location URL: http://doi.org/10.1016/j.parkreldis.2014.09.010Citation Count: 46
-
OPENTitle: Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in ratsJournal Name: NeurosciencePublisher: Elsevier BVVol: 318Issue #:Start Page: 157End Page: 165Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2016.01.020Best OA location URL: http://doi.org/10.1016/j.neuroscience.2016.01.020Citation Count: 93
-
OPENTitle: Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and InternalizationJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 291Issue #: 9Start Page: 4374End Page: 4385Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.m115.705095Best OA location URL: http://www.jbc.org/article/S0021925820435859/pdfCitation Count: 145
-
RESTRICTEDTitle: Erythropoietin and small molecule agonists of the tissue-protective erythropoietin receptor increase FXN expression in neuronal cells in vitro and in Fxn-deficient KIKO mice in vivoJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 123Issue #:Start Page: 34End Page: 45Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2017.05.011Citation Count: 11
-
OPENTitle: CoREST Complex-Selective Histone Deacetylase Inhibitors Show Prosynaptic Effects and an Improved Safety Profile To Enable Treatment of SynaptopathiesJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 10Issue #: 3Start Page: 1729End Page: 1743Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.8b00620Citation Count: 42